Dr. Martens PLC (DOCS) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.392x

Based on the latest financial reports, Dr. Martens PLC (DOCS) has a cash flow conversion efficiency ratio of 0.392x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX141.60 Million ≈ $17.23K USD) by net assets (GBX361.50 Million ≈ $43.98K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Dr. Martens PLC market cap and net worth for the company's overall valuation and market capitalisation.

Dr. Martens PLC - Cash Flow Conversion Efficiency Trend (2014–2026)

This chart illustrates how Dr. Martens PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Dr. Martens PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dr. Martens PLC ranked by their cash flow conversion efficiency. Explore Dr. Martens PLC (DOCS) cash flow quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Humax Holdings Co. Ltd
KQ:028080
0.092x
Arb Bhd
KLSE:7181
0.000x
Norfolk Metals Ltd
AU:NFL
-0.059x
NINE MILE METALS LTD
F:KQ9
-0.097x
Durango Resources Inc.
V:DGO
0.017x
Schroders Investment Trusts - Schroder Asian Total Return Investment Company plc
LSE:ATR
0.005x
EMC Public Company Limited
BK:EMC
-0.068x
Forum Energy Metals Corp
V:FMC
0.046x

Annual Cash Flow Conversion Efficiency for Dr. Martens PLC (2014–2026)

The table below shows the annual cash flow conversion efficiency of Dr. Martens PLC from 2014 to 2026. View DOCS share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 GBX361.50 Million
≈ $43.98K
GBX125.50 Million
≈ $15.27K
0.347x -35.20%
2025-03-31 GBX366.40 Million
≈ $44.58K
GBX196.30 Million
≈ $23.88K
0.536x +17.49%
2024-03-31 GBX368.20 Million
≈ $44.80K
GBX167.90 Million
≈ $20.43K
0.456x +138.44%
2023-03-31 GBX404.20 Million
≈ $49.18K
GBX77.30 Million
≈ $9.41K
0.191x -65.96%
2022-03-31 GBX328.20 Million
≈ $39.93K
GBX184.40 Million
≈ $22.44K
0.562x -30.25%
2021-03-31 GBX150.70 Million
≈ $18.34K
GBX121.40 Million
≈ $14.77K
0.806x -53.22%
2020-03-31 GBX70.50 Million
≈ $8.58K
GBX121.40 Million
≈ $14.77K
1.722x +125.83%
2019-03-31 GBX-8.40 Million
≈ $-1.02K
GBX56.00 Million
≈ $6.81K
-6.667x -326.09%
2018-03-31 GBX-29.40 Million
≈ $-3.58K
GBX46.00 Million
≈ $5.60K
-1.565x +18.13%
2017-03-31 GBX-18.00 Million
≈ $-2.19K
GBX34.40 Million
≈ $4.19K
-1.911x +18.52%
2016-03-31 GBX-11.00 Million
≈ $-1.34K
GBX25.80 Million
≈ $3.14K
-2.345x -109.48%
2015-03-31 GBX800.00K
≈ $97.34
GBX19.80 Million
≈ $2.41K
24.750x +643.39%
2014-03-31 GBX1.51 Million
≈ $183.60
GBX5.02 Million
≈ $611.28
3.329x --

About Dr. Martens PLC

LSE:DOCS UK Footwear & Accessories
Market Cap
$7.84 Million
GBX64.41 Billion GBX
Market Cap Rank
#27750 Global
#390 in UK
Share Price
GBX67.30
Change (1 day)
+0.45%
52-Week Range
GBX60.70 - GBX99.35
All Time High
GBX470.02
About

Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.